难治性肝硬化腹水41例疗效分析  

Clinical analysis of 41 cases with refractory cirrhosis ascites

作　　者：孟敏[1] Meng Min(Infectious Disease Department,the Third Affiliated Hospital of Xuzhou Medical College 221003)

机构地区：[1]徐州医学院附属第三医院感染性疾病科,221003

出　　处：《中国社区医师》2016年第31期55-55,57,共2页Chinese Community Doctors

摘　　要：目的:探讨难治性肝硬化腹水的治疗方法。方法:收治难治性乙肝肝硬化腹水患者41例,放腹水后,静脉滴注人血白蛋白,联合20%甘露醇及多巴胺静脉滴注,观察治疗效果。结果:治疗后,有效率85.37%,血钠、血钾趋于正常,不良反应较轻。结论:多巴胺联合甘露醇是治疗难治性肝硬化腹水的有效药物,安全性好。Objective:To explore the treatment of refractory cirrhosis ascites.Methods:41 patients with refractory hepatitis B cirrhosis ascites were selected.They were given intravenous infusion of human albumin,combined with 20% mannitol and dopamine for intravenous infusion,and we observed the therapeutic effect.Results:After treatment,the effective rate was 85.37%,the blood sodium and potassium were normal,and the adverse reactions were mild.Conclusion:Dopamine combined with mannitol were effective drugs in the treatment of refractory cirrhotic ascites,and the security was good.

关 键 词：难治性肝硬化腹水 多巴胺 甘露醇 

分 类 号：R575.2[医药卫生—消化系统]